tiprankstipranks
Trending News
More News >
Clal Biotechnology Industries Ltd (IL:CBI)
:CBI
Israel Market

Clal Biotech (CBI) Income Statement

Compare
0 Followers

Clal Biotech Income Statement

Last quarter (Q2 2025), Clal Biotech's total revenue was 0.00, a decrease of ― from the same quarter last year. In Q2, Clal Biotech's net income was -5.17M. See Clal Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
433.00K 104.00K 370.00K 224.00K 206.00K
Gross Profit
-183.00K 104.00K 370.00K 224.00K 206.00K
Operating Expenses
6.34M 10.29M 12.27M 77.47M 10.30M
Depreciation and Amortization
283.00K 526.00K 17.64M 22.51M 23.87M
EBITDA
-6.34M -24.02M 64.22M -55.08M 13.23M
Operating Income
-6.34M -10.18M -27.42M -77.59M 40.15M
Other Income/Expenses
-68.73M -17.91M -13.61M 11.00M 9.68M
Pretax Income
-75.07M -28.09M -41.02M -66.59M 49.84M
Net Income
-62.46M -31.05M -61.74M -89.58M 109.03M
Per Share Metrics
Basic EPS
-0.40 -0.20 -0.39 -0.57 0.68
Diluted EPS
-0.40 -0.20 -0.39 -0.57 0.68
Weighted Average Shares Outstanding
158.44M 156.85M 156.85M 158.44M 161.24M
Weighted Average Shares Outstanding (Diluted)
158.44M 156.85M 156.85M 158.44M 161.24M
Currency in ILS

Clal Biotech Earnings and Revenue History